Impact of pediatric obesity on abdominal surgery outcome: a narrative review

Gloria Pelizzo1,2, Valeria Calcaterra3,4, Michela Marinaro2

  • 1Department of Biomedical and Clinical Science, University of Milan, Milan, Italy.

Insights

Childhood obesity increases surgical risks, leading to more complications and longer hospital stays in pediatric abdominal surgery. However, tailored perioperative care can significantly improve outcomes for these children.

Area of Science:

  • Pediatric Surgery
  • Obesity Medicine
  • Perioperative Care

Background:

  • Childhood obesity is a growing global health issue impacting pediatric surgical patients.
  • Obesity presents unique anatomical, physiological, and immunometabolic challenges in children undergoing abdominal surgery.
  • Understanding these challenges is crucial for optimizing surgical management and outcomes.

Purpose of the Study:

  • To review and synthesize current evidence on how childhood obesity affects surgical outcomes in pediatric abdominal procedures.
  • To identify specific risks and complications associated with obesity in this patient population.
  • To highlight strategies for improving perioperative management.

Main Methods:

  • A narrative literature review was performed using major scientific databases (PubMed, Scopus, Embase).
  • Studies published within the last 15 years were prioritized, focusing on large cohort studies and national registries.
  • Evidence was synthesized thematically, without formal meta-analysis or risk-of-bias assessment.

Main Results:

  • Children with obesity undergoing abdominal surgery face higher risks of respiratory events, wound complications, extended operative times, and prolonged hospital stays.
  • Comorbidities like obstructive sleep apnea syndrome (OSAS) and cardiometabolic dysfunction exacerbate these risks.
  • Outcomes vary by surgical procedure, with multidisciplinary strategies showing promise in mitigating complications.

Conclusions:

  • Obesity acts as a risk amplifier, not a surgical contraindication, in pediatric abdominal surgery.
  • Personalized perioperative management and adapted Enhanced Recovery After Surgery (ERAS) pathways are essential.
  • These tailored approaches can reduce complications, optimize resource use, and enhance outcomes for obese children requiring surgery.
Abstract

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
401
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
345
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
296
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
811
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
873